
AbCellera Biologics Inc (ABCL) last month performance of 23.42% certainly makes it a sizzling prospect
Witnessing the stock’s movement on the chart, on Thursday, AbCellera Biologics Inc (NASDAQ: ABCL) had a quiet start as it plunged -3.94% to $3.9, before